RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Rivaroxaban Improves Outcomes in Patients with Acute Coronary Syndromes
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 15
SP 10
OP 11
DO 10.1177/155989771115003
UL http://mdc.sagepub.com/content/11/15/10.abstract
AB Results from the Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 51 [ATLAS ACS 2-TIMI 51; NCT00809965] Trial showed that rivaroxaban significantly reduced the risk of cardiovascular death, myocardial infarction, and stroke in acute coronary syndrome patients.